본문으로 바로가기 주메뉴 바로가기

사용자별 맞춤메뉴

자주찾는 메뉴

추가하기
닫기

연구성과

contents area

detail content area

Genetic variations associated with response to dutasteride in the treatment of male subjects with ..
  • 작성일2020-05-07
  • 최종수정일2020-05-07
  • 담당부서연구기획과
  • 연락처043-719-8033
  • 289

PLoS One, 2019. 14(9), e0222533-, DOI: https://doi.org/10.1371/journal.pone.0222533


Genetic variations associated with response to dutasteride in the treatment of male subjects with androgenetic alopecia

Arang Rhie, Ho-Young Son;Soo Jung Kwak;Seungbok Lee;Dong Young Kim;Bark-Lynn Lew;Woo-Young Sim;Jeong-Sun


Abstract

    Dutasteride, a dual inhibitor of both type I and II 5α-reductases, is used to treat male patternhair loss (MPHL). However, patient response to dutasteride varies in each individual, thecause of which is yet to be identified. To identify genetic variants associated with responseto dutasteride treatment for MPHL, a total of 42 men with moderate MPHL who had beentreated with dutasteride for 6 months were genotyped and analysed by quantitative linearregression, case-control association tests, and Fisher’s exact test. The synonymous singlenucleotide polymorphism (SNP) rs72623193 in DHRS9 was most significantly associatedwith response to dutasteride, followed by the non-synonymous SNP rs2241057 in CYP26B1.Additionally, variants in ESR1, SRD5A1, CYP19A1, and RXRG are suggested to be associatedwith response to dutasteride. Cumulative effect and interaction among these SNPswere presented in both additive and non-additive models.



  • 본 연구는 질병관리본부 연구개발과제연구비를 지원받아 수행되었습니다.
  • This research was supported by a fund by Research of Korea Centers for Disease Control and Prevention.


본 공공저작물은 공공누리  출처표시 조건에 따라 이용할 수 있습니다 본 공공저작물은 공공누리 "출처표시" 조건에 따라 이용할 수 있습니다.
TOP